Recent research highlights the development of magneto-NIR-II-programmed cascade nanozymes that facilitate blood-brain barrier translocation and enhance autophagic resistance in glioblastoma. This innovative approach could pave the way for more effective treatments targeting this aggressive brain tumor.
magneto nir ii programmed cascade nanozymes unlocking blood brain barrier translocation and autophagic resistance in glioblastoma
Original title: “Magneto-NIR-II-Programmed Cascade Nanozymes Unlocking Blood-Brain Barrier Translocation and Autophagic Resistance in Glioblastoma.”